Insmed: Stifel Raises PT to $208 from $205, Maintains Buy Rating

Tuesday, Mar 24, 2026 9:33 am ET1min read
INSM--

Insmed: Stifel Raises PT to $208 from $205, Maintains Buy Rating

Insmed: Stifel Raises PT to $208 from $205, Maintains Buy Rating

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet